CS logo
small CS logo
General Hospital "Djordje Joanovic"

Zrenjanin, Serbia
Hospital in Zrenjanin
Bolnička Dr Vase Savića br. 5, Zrenjanin 23000

About General Hospital "Djordje Joanovic"


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Janssen Research & Development, LLC
5
Hoffmann-La Roche
4
Pfizer
4
Genentech, Inc.
2
Abivax S.A.
1
Boehringer Ingelheim
1
GB004, Inc.
1
Light Chain Bioscience - Novimmune SA
1
Mast Therapeutics, Inc.
1
Total Rows: 10

Clinical Trials at General Hospital "Djordje Joanovic"


During the past decade, General Hospital "Djordje Joanovic" conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 8 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22003355443311330000110000002244Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trial in Patients With Metastatic Colorectal Cancer
2005-05-01
Completed
300
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
2017-02-03
2021-05-10
Completed
319
Study of an Anti-TLR4 mAb in Rheumatoid Arthritis
2017-05-10
2018-06-20
Completed
90

Rows per page:

1–25 of 25

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "General Hospital "Djordje Joanovic"" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored and "Genentech, Inc." with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital "Djordje Joanovic"" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 5Eli Lilly and Company: 5Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4Pfizer: 4Pfizer: 4Genentech, Inc.: 2Genentech, Inc.: 2Abivax S.A.: 1Abivax S.A.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1GB004, Inc.: 1GB004, Inc.: 1Light Chain Bioscience -Novimmune SA: 1Light Chain Bioscience -Novimmune SA: 1Mast Therapeutics, Inc.: 1Mast Therapeutics, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at General Hospital "Djordje Joanovic"


According to Clinical.Site data, the most researched conditions in "General Hospital "Djordje Joanovic"" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (5 trials), "Crohn Disease" (3 trials), "Colitis, Ulcerative" (1 trials) and "Colon Cancer" (1 trials). Many other conditions were trialed in "General Hospital "Djordje Joanovic"" in a lesser frequency.

Clinical Trials Intervention Types at General Hospital "Djordje Joanovic"


Most popular intervention types in "General Hospital "Djordje Joanovic"" are "Drug" (25 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (4 trials), "Mirikizumab" (4 trials), "Etrolizumab" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

Clinical Trials Genders at General Hospital "Djordje Joanovic"


The vast majority of trials in "General Hospital "Djordje Joanovic"" are 25 trials for "All" genders.

Clinical Trials Status at General Hospital "Djordje Joanovic"


Currently, there are NaN active trials in "General Hospital "Djordje Joanovic"". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in General Hospital "Djordje Joanovic", undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital "Djordje Joanovic", 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 15Phase 3: 15Phase 2: 11Phase 2: 11Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 7Active, not recruiting: 7Recruiting: 7Recruiting: 7Terminated: 2Terminated: 2